Your weekly roundup of the latest news from Drug Topics®.
Lenacapavir was approved with the FDA's Breakthrough Therapy Designation.
In the midst of an opioid epidemic, CBD may help patients experiencing opioid withdrawal symptoms find relief.
Research tells a different story than recent news headlines.
The Medicare Part D Senior Savings Model—a CMS effort to test $35 copays for insulin—led to lowered total costs for beneficiaries.
The COVID-19 vaccine rate for teenagers lags behind vaccination rates for adults. Does parental hesitancy for vaccines in general play a role?
Read more